secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silk Road Medical Inc (—)
CIK:        0001397702
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001397702-23-000061
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silk Road Medical names Chas McKhann CEO effective Nov 2, 2023; Erica Rogers retires
--------------------------------------------------------------------------------

- Chas McKhann appointed CEO and director effective November 2, 2023, succeeding Erica Rogers who retired.
- McKhann receives $650K base salary, $100K sign-on bonus, target bonus of 100% of salary.
- McKhann granted 612,083 RSUs (4-year vesting) and 612,083 PSUs (relative TSR performance vesting).
- Rogers enters consulting agreement for one year at $55K/month; her PSUs forfeited, RSUs accelerate, option extension.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1397702/000139770223000061/0001397702-23-000061-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1397702/000139770223000061/silk-20231102x8k.htm
  HTML page:      https://secwatch.observer/filing/0001397702-23-000061

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer